EUVIMEDEUVIMED entdecken
Open Access

Thrombolysis by recombinant tissue plasminogen activator-immobilized magnetic nanoparticles coated with chitosan: a comparative study

Seyedeh Parnian Banikarimi, Seyed Hossein Ahmadi Tafti, Masoud Soleimani, Asieh Heirani-Tabasi, Hassan Maleki, Hadi Baharifar, Kamyar Khoshnevisan iD

In vitro models · 11.08.2026 · 5 (4) · 839-849

DOI: 10.1007/s44164-026-00151-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In vitro models, online erschienen am 11.08.2026. Verfasst von Seyedeh Parnian Banikarimi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Advanced Technologies in Cardiovascular Medicine, Cardiovascular Diseases Research Institute, Tehran Heart Center, Tehran Univers…. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Tehran University of Medical Sciences and Health Services.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study explores the thrombolytic potential of recombinant tissue plasminogen activator (rtPA) immobilized on chitosan-coated magnetic nanoparticles (rtPA-CS-MNPs) in comparison with free rtPA and commercialized MNPs (CMNPs). The objective was to evaluate whether MNPs immobilization enhances stability, prolongs enzymatic activity, and improves clot dissolution efficiency under in vitro conditions. Methods: rtPA was immobilized onto CS-coated MNPs via covalent bonding. Characterization was performed using dynamic light scattering (DLS) for size and zeta potential (ZP) analysis, Fourier-transform infrared spectroscopy (FTIR), and transmission electron microscopy (TEM). In vitro thrombolysis assays were conducted using fibrin clots prepared from human plasma. Comparative analysis was performed between rtPA-CS-MNPs, rtPA-CMNPs, and free rtPA. Results: rtPA-CS-MNPs demonstrated sustained enzymatic activity with consistently higher OD values compared to free rtPA and CMNPs. DLS and ZP of rtPA-CS-MNPs were around 152 and - 9, respectively. FTIR results confirmed that CS successfully coated MNPs as well as rtPA immobilized into CS-MNPs. TEM images exhibited mainly spherical MNPs in the 20-50 nm range. The findings suggested that MNPs, CS, and the administered dose of rtPA are safe for potential in vivo applications. The immobilized formulation demonstrated prolonged stability, reduced degradation, and enhanced clot-dissolution efficacy over 24 h. Blank controls confirmed that activity was attributable to rtPA immobilization rather than nanoparticle interference.

Conclusion

The findings indicate that rtPA-CS-MNPs provide superior thrombolytic activity compared to free rtPA, with advantages in stability and sustained release. This comparative study highlights the potential of CS-coated MNPs as a promising platform for controlled and efficient thrombolytic therapy.

Schlagwörter

Stichwörter der Autor:innen

Chitosan coatingComparative analysisMagnetic nanoparticlesRecombinant tissue plasminogen activatorThrombolytic activity

Autor:innen und Institutionen

  • Research Center for Advanced Technologies in Cardiovascular Medicine, Cardiovascular Diseases Research Institute, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, 1417653761 Iran.
  • Department of Biomedical Engineering, SR.C., Islamic Azad University, Tehran, Iran.
  • Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
  • Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Medical Nanotechnology and Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, 1983963113 Iran.

ORCID-Profile: Kamyar Khoshnevisan

Förderung

  • Tehran University of Medical Sciences and Health Services

Zitieren

APA

Banikarimi, S. P., Tafti, S. H. A., Soleimani, M., Heirani-Tabasi, A., Maleki, H., Baharifar, H., & Khoshnevisan, K. (2026). Thrombolysis by recombinant tissue plasminogen activator-immobilized magnetic nanoparticles coated with chitosan: a comparative study. In vitro models, 5(4), 839-849. https://doi.org/10.1007/s44164-026-00151-9

Vancouver

Banikarimi SP, Tafti SHA, Soleimani M, Heirani-Tabasi A, Maleki H, Baharifar H, et al. Thrombolysis by recombinant tissue plasminogen activator-immobilized magnetic nanoparticles coated with chitosan: a comparative study. In vitro models. 2026;5(4):839-849. doi:10.1007/s44164-026-00151-9

BibTeX
@article{Banikarimi2026,
  author = {Banikarimi, Seyedeh Parnian and Tafti, Seyed Hossein Ahmadi and Soleimani, Masoud and Heirani-Tabasi, Asieh and Maleki, Hassan and Baharifar, Hadi and Khoshnevisan, Kamyar},
  title = {Thrombolysis by recombinant tissue plasminogen activator-immobilized magnetic nanoparticles coated with chitosan: a comparative study},
  journal = {In vitro models},
  year = {2026},
  volume = {5},
  number = {4},
  pages = {839--849},
  doi = {10.1007/s44164-026-00151-9}
}
Kostenlos starten →